XRHealth makes another acquisition, aiming to be a leading virtual provider using VR
XRHealth is acquiring RealizedCare, a company that couples immersive experiences with coaches for chronic pain management.
Related Articles
Future Directions and Research Priorities in BTKi Treatment Approaches
Panelists discuss how challenges in implementing emerging Bruton tyrosine kinase inhibitor (BTKi) regimens for treatment-naive patients with chronic lymphocytic leukemia (CLL) and mantle cell lymphoma…
Duchenne gene therapy from Solid Biosciences produces promising results in early study
Solid said that the first patients to receive its Duchenne gene therapy all produced high levels of the target protein, an early sign of promise
Mass. (un)vaccination: A new wave of vaccine skepticism threatens readiness for the next pandemic – The Boston Globe
Health care providers say that hesitation and outright resistance to vaccines have become disturbingly common even in Massachusetts, a state that was at the forefront…
Let your mind protect your heart
Stress is hard on your heart. But all you need is a few minutes a day to relax into healthier blood pressure and lower cardiac…
The development of an innovative method to improve the dissolution performance of rivaroxaban
Recent advancements in the formulation of solid dosage forms involving active ingredient-cyclodextrin complexes have garnered considerable attention in pharmaceutical research. While previous studies predominantly focused…
Duchenne gene therapy from Solid Biosciences produces promising results in early study
Solid said that the first patients to receive its Duchenne gene therapy all produced high levels of the target protein, an early sign of promise
A Kid Made a Small Fortune Selling Off a Memecoin He’d Made on a Lark. Then Came the Backlash
ON THE EVENING of November 19, art adviser Adam Biesk was finishing work at his California home when he overheard a conversation between his wife…
Biogen partners with Stoke Therapeutics on drug for severe epilepsy
Biogen and Stoke Therapeutics have signed a deal to co-develop and sell Stoke’s experimental drug for Dravet syndrome, outside the U.S.
EU joint defence debt has many hoops to go through
Europe’s leaders are caught between the need to boost their defence spending in a hurry, and their tight finances. The European leaders gathered by French…
